Literature DB >> 7798889

Genotype distribution of hepatitis C virus infection in Taiwan.

J S Wu1, H F Lee, H L Hsiau, H Y Lu, W H Chou, C F Lu, H Y Chen, F N Lee, P Y Chen, K M Tam.   

Abstract

To investigate the prevalence of genotype distribution of hepatitis C virus (HCV) infection in Taiwan, genotypes were identified in 122 (36 anti-HCV-positive blood donors, 44 anti-HCV-positive aborigines, 28 hemodialysis patients, and 14 patients with chronic liver diseases) of 280 subjects, using polymerase chain reaction by Okamoto's type-specific primer method. Type II was the dominant (66.7%) type among anti-HCV-positive blood donors, followed by type III and type IV with the same percentages (16.7%), while none of type I was detected. The prevalence of genotype distribution were 75.0%, 81.1%, and 64.3% for type II, 4.6%, 17.9%, and 21.4% for type III, 13.6%, 0%, and 7.1% for type IV, for the aborigines, hemodialysis, and chronic liver diseases groups, respectively. Four subjects revealed mixed infections by two different genotypes: two cases of II and III; and each one case of II and IV, and III and IV. Diverse genotype distributions in two hemodialysis groups disclose the existence of obvious regional differences even within a region. The results reveal the highest prevalence of type II as in Japan. However, there is a higher prevalence rate of type IV than in Japan.

Entities:  

Mesh:

Year:  1994        PMID: 7798889     DOI: 10.1002/jmv.1890440114

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

Review 1.  Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

Authors:  Evan B Cunningham; Tanya L Applegate; Andrew R Lloyd; Gregory J Dore; Jason Grebely
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

2.  Determination of genotypes of hepatitis C virus in Venezuela by restriction fragment length polymorphism.

Authors:  F H Pujol; C L Loureiro; M Devesa; L Blitz; K Parra; S Beker; F Liprandi
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan.

Authors:  Chia-Yen Dai; Ming-Lung Yu; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wan-Long Chuang; Wen-Yu Chan
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 4.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

5.  Ropeginterferon alfa-2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy.

Authors:  Hsien-Hong Lin; Shih-Jer Hsu; Sheng-Nan Lu; Wan-Long Chuang; Chao-Wei Hsu; Rong-Nan Chien; Sien-Sing Yang; Wei-Wen Su; Jaw-Ching Wu; Tzong-Hsi Lee; Cheng-Yuan Peng; Kuan-Chiao Tseng; Albert Qin; Yi-Wen Huang; Pei-Jer Chen
Journal:  JGH Open       Date:  2021-07-10

6.  Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution.

Authors:  Hung-Da Tung; Pei-Lun Lee; Jyh-Jou Chen; Hsing-Tao Kuo; Ming-Jen Sheu; Chun-Ta Cheng; Tang-Wei Chuang; Hsu-Ju Kao; Yu-Hsun Wu; Mai-Gio Pang; Cheng-Heng Lin; Chia-Yi Hou; Hsin-Hua Tsai; Li-Ching Wu; Chuan Lee
Journal:  Viruses       Date:  2021-07-07       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.